Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments

被引:5
作者
Bakre, Shivani [1 ]
Chang, Hsien-Yen [2 ]
Doshi, Jalpa A. [3 ,4 ]
Goedel, William C. [5 ]
Saberi, Parya [6 ]
Chan, Philip A. [7 ]
Nunn, Amy [7 ]
Dean, Lorraine T. [1 ,2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA USA
[5] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] Brown Univ, Dept Med, Providence, RI USA
基金
美国国家卫生研究院;
关键词
PREEXPOSURE PROPHYLAXIS; PATIENT ADHERENCE; PROVIDERS;
D O I
10.1001/jamainternmed.2024.3998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Clinicians are a key component of preexposure prophylaxis (PrEP) care. Yet, no prior studies have quantitatively investigated how PrEP adherence differs by clinician specialty. Objective To understand the association between prescribing clinician specialty and patients not picking up (reversal/abandonment) their initial PrEP prescription. Design, Setting, and Participants This cross-sectional study of patients who were 18 years or older used pharmacy claims data from 2015 to 2019 on new insurer-approved PrEP prescriptions that were matched with clinician data from the US National Plan and Provider Enumeration System. Data were analyzed from January to May 2022. Main Outcomes and Measures Clinician specialties included primary care practitioners (PCPs), infectious disease (ID), or other specialties. Reversal was defined as a patient not picking up their insurer-approved initial PrEP prescription. Abandonment was defined as a patient who reversed and still did not pick their prescription within 365 days. Results Of the 37 003 patients, 4439 (12%) were female and 32 564 (88%) were male, and 77% were aged 25 to 54 years. A total of 24 604 (67%) received prescriptions from PCPs, 3571 (10%) from ID specialists, and 8828 (24%) from other specialty clinicians. The prevalence of reversals for patients of PCPs, ID specialists, and other specialty clinicians was 18%, 18%, and 25%, respectively, and for abandonments was 12%, 12%, and 20%, respectively. After adjusting for confounding, logistic regression models showed that, compared with patients who were prescribed PrEP by a PCP, patients prescribed PrEP by ID specialists had 10% lower odds of reversals (odds ratio [OR], 0.90; 95% CI, 0.81-0.99) and 12% lower odds of abandonment (OR, 0.88; 95% CI, 0.78-0.98), while patients prescribed by other clinicians had 33% higher odds of reversals (OR, 1.33; 95% CI, 1.25-1.41) and 54% higher odds of abandonment (OR, 1.54; 95% CI, 1.44-1.65). Conclusion The results of this cross-sectional study suggest that PCPs do most of the new PrEP prescribing and are a critical entry point for patients. PrEP adherence differs by clinician specialties, likely due to the populations served by them. Future studies to test interventions that provide adherence support and education are needed.
引用
收藏
页码:1204 / 1211
页数:8
相关论文
共 50 条
  • [41] Unwillingness to prescribe PrEP by health care professionals of specialized HIV/AIDS services in Northeastern Brazil
    Lamonica, Juliana de Souza
    Magno, Laio
    Santos, Julia Elen Jesus da Silva
    Dourado, Ines
    dos Santos, Adriano Maia
    Pereira, Marcos
    [J]. CADERNOS DE SAUDE PUBLICA, 2023, 39
  • [42] Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission
    Whiteside-Mansell, Leanne
    Sockwell, LaTunja
    Knight, Daniel
    Crone, Cynthia
    [J]. AIDS AND BEHAVIOR, 2021, 25 (08) : 2578 - 2590
  • [43] Perspectives on HIV PrEP care in Germany: qualitative insights from primary care physicians and specialists
    Plomer, Anna-Sophie
    McCool-Myers, Megan
    Apfelbacher, Christian
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (08): : 994 - 1000
  • [44] Assessing Knowledge, Practices, and Barriers to PrEP and nPEP Prescription Among Texas Healthcare Providers
    Tiruneh, Yordanos M.
    Rachmale, Ruchi
    Elerian, Nagla
    Lakey, David L.
    [J]. HEALTHCARE, 2024, 12 (22)
  • [45] Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention
    Ngure, Kenneth
    Mugo, Nelly R.
    Bukusi, Elizabeth A.
    Kiptinness, Catherine
    Oware, Kevin
    Gakuo, Stephen
    Musinguzi, Nicholas
    Pyra, Maria
    Garrison, Lindsey
    Baeten, Jared M.
    Haberer, Jessica E.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (04) : E30 - E32
  • [46] PrEP initiation and adherence among Black cisgender women in Mississippi: The role of HIV and PrEP stigma and social support
    Knight, Deja
    Monger, Mauda
    Phillips, Karlye
    Antar, Amina
    Baral, Stefan
    Stockman, Jamila K.
    Nunn, Amy
    Chan, Philip
    Mayer, Kenneth
    Mena, Leandro
    Kershaw, Trace
    Willie, Tiara C.
    [J]. WOMENS HEALTH, 2024, 20
  • [47] MODELING AND OPTIMAL CONTROL OF HIV/AIDS PREVENTION THROUGH PREP
    Silva, Cristiana J.
    Torres, Delfim F. M.
    [J]. DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES S, 2018, 11 (01): : 119 - 141
  • [48] PrEP as Peri-conception HIV Prevention for Women and Men
    Heffron, Renee
    Pintye, Jillian
    Matthews, Lynn T.
    Weber, Shannon
    Mugo, Nelly
    [J]. CURRENT HIV/AIDS REPORTS, 2016, 13 (03) : 131 - 139
  • [49] Optimizing HIV PrEP Persistence: Does Your Pharmacy Matter?
    Whelchel, Kristen
    Zuckerman, Autumn D.
    DeClercq, Josh
    Choi, Leena
    Kelly, Sean G.
    [J]. AIDS AND BEHAVIOR, 2023, 27 (11) : 3735 - 3744
  • [50] Cultural discourses and HIV/AIDS activists' meanings about PrEP
    D'Amours, Jason V.
    [J]. CULTURE HEALTH & SEXUALITY, 2023, 25 (10) : 1340 - 1354